School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Department of Biotechnology, College of Biomedical Sciences Technology & Research, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India.
Adv Protein Chem Struct Biol. 2020;120:379-408. doi: 10.1016/bs.apcsb.2019.11.005. Epub 2020 Feb 4.
Blau syndrome (BS), which affects the eyes, skin, and joints, is an autosomal dominant genetic inflammatory disorder. BS is caused by mutations in the NOD2 gene. However, there are no direct treatments, and treatment with conventional anti-inflammatory drugs such as adrenal glucocorticoids, anti-metabolites, and biological agents such as anti-TNF and infliximab have all been attempted with varying degrees of success. In this study, we tried to identify all the reported mutations in the NOD2 protein that cause BS. Collectively, 114 missense mutations were extracted from the UniProt, ClinVar, and HGMD databases. The mutations were further subjected to pathogenic, stability, and conservation analyses. According to these computational analyses, six missense mutations (R334Q, R334W, E383G, E383K, R426H, and T605P) were found to be highly deleterious, destabilizing, and positioned in the conserved position. ADP to ATP conversion plays a crucial role in switching the closed-form of NOD2 protein to the open-form, thus activating the protein. Accordingly, the mutations in the ADP binding sites have received more attention in comparison to the mutations in the non-ADP binding positions. Interestingly, the W490L mutation is positioned in the ADP binding site and exhibits highly deleterious and destabilizing properties. Additionally, W490L was also found to be conserved, with a ConSurf score of 7. Therefore, we further performed homology modeling to determine the 3D structure of native NOD2 and the W490L mutant. Molecular docking analysis was carried out to understand the change in the interaction of ADP with the NOD2 protein. We observed that ADP had a stronger interaction with the native NOD2 protein compared to the W490L mutant. Finally, ADP complexed with native NOD2 and W490L mutant were subjected to molecular dynamics simulations, and the trajectories were analyzed. In the simulations, we observed decreased deviation and fluctuations in native NOD2, whereas decreased compactness and inter- and intramolecular hydrogen bonds were observed in the W490L mutant. This study is expected to serve as a platform for developing targeted drug therapy for BS.
布劳综合征(BS)是一种常染色体显性遗传的炎症性疾病,主要影响眼睛、皮肤和关节。BS 是由 NOD2 基因突变引起的。然而,目前尚无直接的治疗方法,曾尝试使用常规抗炎药物(如肾上腺糖皮质激素、抗代谢物和 TNF 拮抗剂等生物制剂)进行治疗,但疗效不一。本研究试图鉴定引起 BS 的所有 NOD2 蛋白报道突变。从 UniProt、ClinVar 和 HGMD 数据库中提取了 114 个错义突变。对这些突变进行了致病性、稳定性和保守性分析。根据这些计算分析,发现 6 个错义突变(R334Q、R334W、E383G、E383K、R426H 和 T605P)具有高度的有害性、不稳定性和位于保守位置。ADP 到 ATP 的转换在将 NOD2 蛋白的闭合形式转换为开放形式从而激活蛋白的过程中起着至关重要的作用。因此,与非 ADP 结合位置的突变相比,ADP 结合位点的突变受到了更多的关注。有趣的是,W490L 突变位于 ADP 结合位点,具有高度的有害性和不稳定性。此外,W490L 也被认为是保守的,其 ConSurf 得分是 7。因此,我们进一步进行同源建模,以确定天然 NOD2 和 W490L 突变体的 3D 结构。进行分子对接分析以了解 ADP 与 NOD2 蛋白相互作用的变化。我们观察到,与 W490L 突变体相比,ADP 与天然 NOD2 蛋白的相互作用更强。最后,将 ADP 与天然 NOD2 和 W490L 突变体复合物进行分子动力学模拟,并对轨迹进行分析。在模拟中,我们观察到天然 NOD2 的偏差和波动减小,而 W490L 突变体的紧凑性和分子内和分子间氢键减少。这项研究有望为布劳综合征的靶向药物治疗提供一个平台。